Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q4 2025
Institutional positions in Oric Pharmaceuticals, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 165
- +14 vs. Q3 2025
- Shares held
- 119.7M
- +13.2M (+12.4%) vs. Q3 2025
- Total value
- $979.6M
- −$298.3M (−23.3%) vs. Q3 2025
- New holders
- 35
- 68 more added
- Sold out
- 21
- 34 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 180 | $1.34B |
| Q1 2026 | 182 | $1.51B |
| Q4 2025 | 165 | $979.6M |
| Q3 2025 | 152 | $1.28B |
| Q2 2025 | 142 | $947.6M |
| Q1 2025 | 143 | $442.0M |
| Q4 2024 | 129 | $611.7M |
| Q3 2024 | 122 | $715.1M |
| Q2 2024 | 113 | $478.3M |
| Q1 2024 | 112 | $879.3M |
| Q4 2023 | 92 | $465.9M |
| Q3 2023 | 90 | $290.7M |
| Q2 2023 | 83 | $353.4M |
| Q1 2023 | 71 | $188.5M |
| Q4 2022 | 64 | $192.1M |
| Q3 2022 | 76 | $104.6M |
| Q2 2022 | 83 | $147.1M |
| Q1 2022 | 101 | $181.7M |
| Q4 2021 | 80 | $512.1M |
| Q3 2021 | 82 | $762.1M |
| Q2 2021 | 78 | $639.4M |
| Q1 2021 | 82 | $874.3M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Oric Pharmaceuticals, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AQR Capital Management LLC | 174,279 | $1.43M | 0.00% | +2,354+1.4% | Added |
| Rafferty Asset Management, LLC | 177,179 | $1.45M | 0.01% | +91,587+107.0% | Added |
| Bank of New York Mellon Corp | 187,921 | $1.54M | 0.00% | +12,207+6.9% | Added |
| Wellington Management Group LLP | 191,823 | $1.57M | 0.00% | +41,229+27.4% | Added |
| Russell Investments Group, Ltd. | 207,037 | $1.69M | 0.00% | +202,063+4,062.4% | Added |
| Boothbay Fund Management, LLC | 218,610 | $1.79M | 0.05% | +107,777+97.2% | Added |
| Squarepoint Ops LLC | 229,383 | $1.88M | 0.00% | +198,650+646.4% | Added |
| Jane Street Group, LLC | 244,033 | $2.00M | 0.00% | +181,355+289.3% | Added |
| Woodline Partners LP | 246,534 | $2.02M | 0.01% | 00.0% | Unchanged |
| Superstring Capital Management LP | 255,370 | $2.09M | 1.12% | +166,024+185.8% | Added |
| Kalehua Capital Management LLC | 267,059 | $2.18M | 2.16% | +267,059 | New |
| Atom Investors LP | 289,962 | $2.37M | 0.19% | +147,361+103.3% | Added |
| Victory Capital Management Inc | 332,760 | $2.72M | 0.00% | +200,540+151.7% | Added |
| Y-Intercept (Hong Kong) Ltd | 341,423 | $2.79M | 0.06% | +341,423 | New |
| Connor, Clark & Lunn Investment Management Ltd. | 350,884 | $2.87M | 0.01% | +334,447+2,034.7% | Added |
| JPMorgan Chase & Co | 414,786 | $3.39M | 0.00% | −813,742−66.2% | Reduced |
| Redmile Group, LLC | 448,110 | $3.67M | 0.27% | +448,110 | New |
| Logos Global Management LP | 450,000 | $3.68M | 0.25% | +450,000 | New |
| Polar Capital Holdings Plc | 502,364 | $4.11M | 0.02% | +33,754+7.2% | Added |
| Bank of America Corp | 507,510 | $4.15M | 0.00% | +404,060+390.6% | Added |
| Blue Owl Capital Holdings LP | 515,000 | $4.21M | 1.30% | +515,000 | New |
| Adage Capital Partners GP, L.L.C. | 549,000 | $4.49M | 0.01% | +101,634+22.7% | Added |
| Lord, Abbett & Co. LLC | 564,253 | $4.62M | 0.01% | +564,253 | New |
| Renaissance Technologies LLC | 572,724 | $4.68M | 0.01% | +558,224+3,849.8% | Added |
| NEXTBio Capital Management LP | 615,720 | $5.04M | 2.95% | +615,720 | New |
| Charles Schwab Investment Management Inc | 621,086 | $5.08M | 0.00% | +17,879+3.0% | Added |
| Barclays PLC | 718,535 | $5.88M | 0.00% | +534,444+290.3% | Added |
| UBS Group AG | 734,858 | $6.01M | 0.00% | +395,622+116.6% | Added |
| Northern Trust Corp | 885,475 | $7.24M | 0.00% | −3,060−0.3% | Reduced |
| Balyasny Asset Management LLC | 950,214 | $7.77M | 0.01% | −569,100−37.5% | Reduced |
| Eventide Asset Management, LLC | 952,371 | $7.79M | 0.12% | +864+0.1% | Added |
| Euclidean Capital LLC | 989,410 | $8.09M | 2.19% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 1,004,378 | $8.22M | 1.72% | +572,685+132.7% | Added |
| Siren, L.L.C. | 1,007,575 | $8.24M | 0.25% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 1,063,769 | $8.70M | 0.19% | −33,728−3.1% | Reduced |
| Silverarc Capital Management, LLC | 1,116,604 | $9.13M | 1.32% | −832,204−42.7% | Reduced |
| Morgan Stanley | 1,194,073 | $9.77M | 0.00% | +448,545+60.2% | Added |
| Integral Health Asset Management, LLC | 1,200,000 | $9.82M | 0.50% | +300,000+33.3% | Added |
| Qube Research & Technologies Ltd | 1,205,429 | $9.86M | 0.01% | +1,205,429 | New |
| Franklin Resources Inc | 1,212,547 | $9.92M | 0.00% | +31,218+2.6% | Added |
| Dimensional Fund Advisors LP | 1,227,230 | $10.0M | 0.00% | +433,359+54.6% | Added |
| Royce & Associates LP | 1,507,301 | $12.3M | 0.13% | +48,818+3.3% | Added |
| Geode Capital Management, LLC | 1,750,694 | $14.3M | 0.00% | +119,950+7.4% | Added |
| MPM Oncology Impact Management LP | 1,798,717 | $14.7M | 1.68% | +69,339+4.0% | Added |
| Goldman Sachs Group Inc | 1,939,285 | $15.9M | 0.00% | +1,034,473+114.3% | Added |
| First Turn Management, LLC | 2,010,307 | $16.4M | 1.88% | −149,167−6.9% | Reduced |
| Vivo Capital, LLC | 2,118,384 | $17.3M | 1.12% | −1,008,220−32.2% | Reduced |
| Paradigm Biocapital Advisors LP | 2,401,217 | $19.6M | 0.53% | +2,401,217 | New |
| Citadel Advisors LLC | 2,434,710 | $19.9M | 0.01% | +1,236,706+103.2% | Added |
| FMR LLC | 2,478,922 | $20.3M | 0.00% | −49,126−1.9% | Reduced |
| Point72 Asset Management, L.P. | 2,923,077 | $23.9M | 0.04% | +303,163+11.6% | Added |
| Price T Rowe Associates Inc | 3,295,122 | $27.0M | 0.00% | +423,795+14.8% | Added |
| The Column Group LLC | 3,540,777 | $29.0M | 34.98% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,641,756 | $29.8M | 0.61% | 00.0% | Unchanged |
| NEA Management Company, LLC | 4,118,621 | $33.7M | 1.72% | 00.0% | Unchanged |
| State Street Corp | 4,258,397 | $34.8M | 0.00% | +1,854,458+77.1% | Added |
| Alkeon Capital Management LLC | 4,504,096 | $36.8M | 0.16% | 00.0% | Unchanged |
| Vanguard Group Inc | 4,541,974 | $37.2M | 0.00% | −108,164−2.3% | Reduced |
| Sr One Capital Management, LP | 4,514,929 | $37.8M | 5.34% | 00.0% | Unchanged |
| Pfizer Inc | 5,376,344 | $44.0M | 18.60% | 00.0% | Unchanged |
| VR Adviser, LLC | 5,676,230 | $46.4M | 2.29% | −920,655−14.0% | Reduced |
| BlackRock, Inc. | 5,875,053 | $48.1M | 0.00% | +598,433+11.3% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 6,572,691 | $53.8M | 0.14% | −90.0% | Reduced |
| EcoR1 Capital, LLC | 6,728,116 | $55.0M | 2.52% | 00.0% | Unchanged |
| Nextech Invest, Ltd. | 7,162,637 | $58.6M | 5.66% | 00.0% | Unchanged |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −220,735−100.0% | Sold out |
| Resolute Capital Asset Partners LLC | 0 | $0 | 0.00% | −167,515−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −166,461−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −148,778−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −120,644−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −49,389−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −33,037−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −29,851−100.0% | Sold out |
| Susquehanna Portfolio Strategies, LLC | 0 | $0 | 0.00% | −27,524−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −23,396−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −16,887−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,348−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −15,154−100.0% | Sold out |
| Clear Harbor Asset Management, LLC | 0 | $0 | 0.00% | −15,119−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −17,082−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −13,970−100.0% | Sold out |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | −10,002−100.0% | Sold out |
| JPL Wealth Management, LLC | 0 | $0 | 0.00% | −95−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −34−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Point72 Europe (London) LLP | – | – | – | – | Not filed |